BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 15762832)

  • 1. Tolerability profiles of atypical antipsychotics in the treatment of bipolar disorder.
    McIntyre RS; Konarski JZ
    J Clin Psychiatry; 2005; 66 Suppl 3():28-36. PubMed ID: 15762832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical antipsychotic tolerability and switching strategies in bipolar disorder.
    Liauw SS; McIntyre RS
    Expert Opin Pharmacother; 2010 Dec; 11(17):2827-37. PubMed ID: 20726821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of bipolar mania with atypical antipsychotics.
    Chengappa KN; Suppes T; Berk M
    Expert Rev Neurother; 2004 Nov; 4(6 Suppl 2):S17-25. PubMed ID: 16279862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical antipsychotic augmentation of mood stabilizer therapy in bipolar disorder.
    Bowden CL
    J Clin Psychiatry; 2005; 66 Suppl 3():12-9. PubMed ID: 15762830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety and tolerability of atypical antipsychotics in bipolar disorder.
    Seemüller F; Forsthoff A; Dittmann S; Born C; Bernhard B; Severus WE; Grunze H
    Expert Opin Drug Saf; 2005 Sep; 4(5):849-68. PubMed ID: 16111448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mood stabilizers and atypical antipsychotics: bimodal treatments for bipolar disorder.
    Ketter TA; Nasrallah HA; Fagiolini A
    Psychopharmacol Bull; 2006; 39(1):120-46. PubMed ID: 17065977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressants and antipsychotics in the long-term treatment of bipolar disorder.
    Kusumakar V
    J Clin Psychiatry; 2002; 63 Suppl 10():23-8. PubMed ID: 12392350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Side effects as influencers of treatment outcome.
    Sharif Z
    J Clin Psychiatry; 2008; 69 Suppl 3():38-43. PubMed ID: 18533761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical antipsychotics: efficacy across bipolar disorder subpopulations.
    Dunner DL
    J Clin Psychiatry; 2005; 66 Suppl 3():20-7. PubMed ID: 15762831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of atypical antipsychotics in bipolar disorders.
    Hirschfeld RM
    J Clin Psychiatry; 2003; 64 Suppl 8():15-21. PubMed ID: 12892537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging treatments for bipolar disorder: safety and adverse effect profiles.
    Marken PA; Pies RW
    Ann Pharmacother; 2006 Feb; 40(2):276-85. PubMed ID: 16403851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of diabetes mellitus associated with atypical antipsychotic use among Medicaid patients with bipolar disorder: a nested case-control study.
    Guo JJ; Keck PE; Corey-Lisle PK; Li H; Jiang D; Jang R; L'Italien GJ
    Pharmacotherapy; 2007 Jan; 27(1):27-35. PubMed ID: 17192159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotic agents in the treatment of bipolar mania.
    Tohen M; Vieta E
    Bipolar Disord; 2009 Jun; 11 Suppl 2():45-54. PubMed ID: 19538685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of antipsychotics in children and adolescents.
    Findling RL; Steiner H; Weller EB
    J Clin Psychiatry; 2005; 66 Suppl 7():29-40. PubMed ID: 16124839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsychotics in the treatment of mood disorders and risk of tardive dyskinesia.
    Keck PE; McElroy SL; Strakowski SM; Soutullo CA
    J Clin Psychiatry; 2000; 61 Suppl 4():33-8. PubMed ID: 10739329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and tolerability of emerging pharmacological treatments for bipolar disorder.
    Dunner DL
    Bipolar Disord; 2005 Aug; 7(4):307-25. PubMed ID: 16026484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatments for late-life bipolar disorder.
    Aziz R; Lorberg B; Tampi RR
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and tolerability of bipolar disorder treatment in youth.
    Findling RL
    J Clin Psychiatry; 2009 Nov; 70(11):e44. PubMed ID: 20031092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.
    Goodwin G; Fleischhacker W; Arango C; Baumann P; Davidson M; de Hert M; Falkai P; Kapur S; Leucht S; Licht R; Naber D; O'Keane V; Papakostas G; Vieta E; Zohar J
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):520-32. PubMed ID: 19411165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical antipsychotics in the treatment of mood disorders.
    Jarema M
    Curr Opin Psychiatry; 2007 Jan; 20(1):23-9. PubMed ID: 17143078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.